ACCESS Newswire

The newsfeed available here is provided by our content partner ACCESS Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.

The NewsWire Hub ("X-Billboard") currently comprises five of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 61
6.119,52 S&P · 19,00 Vola-Index · 107.423,91 BTC · 1,16943 EURUSD
System-State: Number of processed items 13.448 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

ACCESS Newswire is an important news source for private investors, investors and traders that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market players in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can use the detailed views of the info cards to directly access the respective news item and other analysis tools.

NEWS
EXPLORER
CA68237C1059
State: 26.06.2025 | 2PM
Do you already know our new terminal view? Click here.
FIGI: BBG01R10BWW9
ONCO
Onco-Innovations Limited
GICS: - · Sector: Diversified Industries · Sub-Sector: -
NAME
Onco-Innovations Limited
ISIN
CA68237C1059
TICKER
ONCO
MIC
XCNQ
REUTERS
ONCO.CD
BLOOMBERG
ONCO CN
Wed, 25.06.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / June 25, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H), (WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Mr. Thomas O'Shaughnessy, Onco-Innovations' CEO, will host a special investors' conference call, on Wednesday, July 2, 2025 at 2:00 p.m. PST/5:0...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Fri, 20.06.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of its wholly-owned subsidiary, Inka Health Corp. ("Inka Health"), have authored a significant new study titled Global Tra...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Fri, 13.06.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / June 13, 2025 / Onco-Innovations Limited (CBOE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement with the University of Alberta and Cross Cancer Institute to undertake a preclinical study that supports the Company's intention ...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Thu, 05.06.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / June 5, 2025 / Onco-Innovations Limited (CBOE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, Inka Health Corp. ("Inka Health"), is launching a new strategic initiative to establish a global consortium dedicated to adv...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Mon, 26.05.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / May 26, 2025 / Onco-Innovations Limited (CBOE:ONCO) (Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Dalton Pharma Services ("Dalton") has commenced activities to manufacture material for preclinical testing of the Company's exclusively-licensed nanopar...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Mon, 26.05.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / May 26, 2025 / Onco-Innovations Limited (CBOE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") announces, further to its news release dated March 25, 2025, that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpr...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 22.05.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / May 22, 2025 / Onco-Innovations Limited (CBOE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointment of Professor Steven Jones as Senior Scientific Advisor. Professor Jones will play a key role in advancing the Company's mission to transfor...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Fri, 16.05.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / May 16, 2025 / Onco-Innovations Limited (CSE:ONCO) ("Onco" or the "Company") is pleased to announce that it will transfer the listing of its common shares (the "Common Shares") to Cboe Canada Inc. ("Cboe Canada") from the Canadian Securities Exchange ("CSE"). Onco e...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 24.04.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / April 24, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ("Inka Health"), signed a new analytical work contract[1] with AstraZeneca Canada ("Ast...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 17.04.2025       Onco-Innovations
CA68237C1059

PNKP TechnologyShown in Past Study to Increase Survival Rate in Colorectal Cancer Bearing Mice VANCOUVER, BC / ACCESS Newswire / April 17, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company")is pleased to announce that it has entered into an agreement with Dalton Pharma Ser...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
Wed, 16.04.2025       Onco-Innovations
CA68237C1059

Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / April 16, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the "...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 10.04.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its subsidiary, Inka Health Corp. ("Inka Health"), has published a significant and novel study titled Quantitative Bias Analysis for the A...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 03.04.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ("Inka Health"), which the Company acquired on or about February 3, 2025 (please see news re...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Wed, 26.03.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology") ...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Tue, 25.03.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-West...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Mon, 24.03.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / March 24, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H), (WKN: A3EKSZ ) (" Onco " or the " Company "), at the request of the Canadian Securities Exchange, provides, by way of the table below, an update to the use of proceeds disclosure contained in its prospectus dated N...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Sun, 02.03.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / March 2, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its CEO, Thomas O'Shaughnessy, was recently featured in an exclusive interview on Conversations That Matter, a widely distributed long-form program s...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Thu, 27.02.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its wholly-owned subsidiary, Inka Health ("Inka"), which has made significant strides in advancing AI-driven oncology re...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Mon, 24.02.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology"),...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Fri, 21.02.2025       Onco-Innovations
CA68237C1059

VANCOUVER, BC / ACCESS Newswire / February 21, 2025 / Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF) (Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health ("Inka"), filed a provisional patent application with the United States Patent and Trademark Of...
Read More
Onco-Innovations
Technical Analysis Termsheet Terminal
Permalink
Silent Ad
ParkerVision
ParkerVision Asks Court to Delay Patent Infringement Trial Against Qualcomm Until Appeal of 2025 Claim Construction Order is Adjudicated
© ACCESSWIRE
Star Copper
Star Copper Upgrades to OTC Markets OTCQX Best Market
© ACCESSWIRE
TransGlobal Assets
TransGlobal Assets Inc. (OTC:TMSH) Officially Launches DateGuard, Its Flagship Emotional Compatibility Dating App
© ACCESSWIRE
XCF Global
XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF
© ACCESSWIRE
Onco-Innovations
Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
© ACCESSWIRE
Cerrado Gold
Cerrado Gold Announces Successful Results of Annual and Special Meeting of Shareholders
© ACCESSWIRE
Ares Dynamic Credit
Month-End Portfolio Data Now Available For Ares Dynamic Credit Allocation Fund, Inc.
© ACCESSWIRE
Paragon Technologies
Mr. Gad Thanks Paragon Stockholders for Their Support of His Slate at the Upcoming Annual Meeting
© ACCESSWIRE
BlackBerry Limited
BlackBerry Announces Election Results for the Company's Board of Directors
© ACCESSWIRE
Organto Foods
Organto Foods Announces Annual General Meeting Results
© ACCESSWIRE
Informa
ADM Toronto Returns Showcasing Advancements in Canadian Market
© ACCESSWIRE
Marijuana
Exousia Pro Files Reg A.
© ACCESSWIRE
Monumental Minerals
Q2 Virtual Investor Summit: Presentations Available Now
© ACCESSWIRE
Stillwater Critical Minerals
Stillwater Critical Minerals Closes First Tranche of Brokered LIFE Offering for Gross Proceeds of C$3.5 Million
© ACCESSWIRE
Goldman Sachs
New to The Street Breaks Interview Records with Global Icons KITON, Goldman Sachs (NYSE: GS), Ford Motors (NYSE: F), and IMG Academy via Merrill Lynch (NYSE: BAC)
© ACCESSWIRE
Paragon Technologies
Independent Proxy Advisory Boards ISS and Glass Lewis Reject Gad's Slate and Endorse Paragon's Director Nominees
© ACCESSWIRE
Rocket Companies
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Companies, Inc. of Class Action Lawsuit and Upcoming Deadlines - RKT
© ACCESSWIRE
Fineqia International
Fineqia Appoints Tether Co-Founder Reeve Collins to Advisory Board
© ACCESSWIRE
Jaguar Health
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
© ACCESSWIRE
Northern Superior Resources
Northern Superior Announces Closing of $5 Million Private Placement and Welcomes NQ Investissement Minier as a Shareholder
© ACCESSWIRE
DigiMax Global
SonicStrategy Approaches 15M Sonic Tokens Staked and Delegated, with 3.7 BTC Held in Treasury
© ACCESSWIRE
Medical Care Technologies
The Grail Collection: MDCE's Infinite Auctions is Back on Track and Set to Showcase High Value Memorabilia at Auction
© ACCESSWIRE
Nocera
Nocera, Inc. Makes Strategic Investment in Tachyonext Inc. to Enter U.S. E-Commerce Market and Expand Consumer Tech Portfolio
© ACCESSWIRE
Ondas
Ondas' American Robotics Partners with Detroit Manufacturing Systems to Scale U.S. Drone Manufacturing to Meet Increasing Demand
© ACCESSWIRE
Sativus Tech
Actress and Influencer Moran Atias Joins Saffron Tech as Brand Ambassador and Investor
© ACCESSWIRE

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the international investor community, we would like to thank AccessWire for providing the news and data feeds

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S